Molecular Diagnostics Market Report – South Africa / MEA

Molecular Diagnostics Market Report – South Africa / MEA

From USD$762.55 million to USD$1,313.21 million by 2028:

The Transformative Trajectory of Molecular Diagnostics in MEA Healthcare

Molecular Diagnostics: A Rapidly Growing Global Market

 

Molecular diagnostics is the analysis of biological markers or genetic material (DNA or RNA) to diagnose diseases, monitor treatment effectiveness, and detect genetic predispositions. It plays a crucial role in healthcare, offering accurate and rapid results. In 2023, the global market is valued at USD$16.6 billion, and it is expected to grow steadily from 2023 to 2028 at an annual rate of 11.4%, reaching approximately USD$28.6 billion.

The expansion of this industry is driven by the increase in prevalence of infectious and chronic diseases, such as cancer, as well as the greater awareness of its benefits, especially among the elderly population. The COVID-19 pandemic has further underscored the importance of such testing for public health.

Researchers continue to enhance methods of methods for screening such as Polymerase Chain Reaction (PCR) and Next-Generation Sequencing (NGS), which makes molecular diagnostics indispensable in a variety of medical fields that range from cancer and infectious diseases to genetic analysis and to comprehend individual drug responses.

This report will provide insights into the market in South Africa and other MEA regions.

 

South Africa’s Molecular Diagnostics Market: A Bright Future Fueled by Technology and Budget

 

To Access The Report 

Related post

Improving Health Services in SADC Region – Excellent Insights  from Angola

Improving Health Services in SADC Region – Excellent Insights…

Highlights Angola’s healthcare has made remarkable progress despite minimal budget increases The SADC region should prioritise coordinated multisectoral actions to address…
South Africa’s Healthcare Sector

South Africa’s Healthcare Sector

Overview of South Africa’s Healthcare Sector South Africa’s healthcare system is set to undergo significant transformation in 2024, with the primary…
How Will Lilly’s Collaboration with a Top Saudi Hospital Revolutionise Early Alzheimer’s Detection?

How Will Lilly’s Collaboration with a Top Saudi Hospital…

Highlights KFSHRC and Eli Lilly Saudi Arabia have signed a MoU to establish a regional Neuroscience Centre for Alzheimer’s disease It…